CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-17 | Bertrand William C JR Chief Operating Officer | Grant or award · Option to purchase Ordinary Shares | +202,800 | 202,800 | ||
| 2023-01-17 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +1,407,072 | 1,407,072 | ||
| 2023-01-17 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +314,256 | 314,256 | ||
| 2023-01-17 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +190,920 | 190,920 | ||
| 2023-01-17 | Brewer Joanna Elizabeth Chief Scientific Officer | Grant or award · Option to purchase Ordinary Shares | +1,407,072 | 1,407,072 | ||
| 2023-01-17 | Brewer Joanna Elizabeth Chief Scientific Officer | Grant or award · Option to purchase Ordinary Shares | +314,256 | 314,256 | ||
| 2023-01-17 | Brewer Joanna Elizabeth Chief Scientific Officer | Grant or award · Option to purchase Ordinary Shares | +135,480 | 135,480 | ||
| 2023-01-17 | TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer | Grant or award · Option to purchase Ordinary Shares | +1,407,072 | 1,407,072 | ||
| 2023-01-17 | TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer | Grant or award · Option to purchase Ordinary Shares | +314,256 | 314,256 | ||
| 2023-01-17 | TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer | Grant or award · Option to purchase Ordinary Shares | +197,064 | 197,064 | ||
| 2023-01-17 | Wood Gavin Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +1,407,072 | 1,407,072 | ||
| 2023-01-17 | Wood Gavin Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +314,256 | 314,256 | ||
| 2023-01-17 | Wood Gavin Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +193,728 | 193,728 | ||
| 2023-01-17 | Norry Elliot Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +1,407,072 | 1,407,072 | ||
| 2023-01-17 | Norry Elliot Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +314,256 | 314,256 | ||
| 2023-01-17 | Norry Elliot Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +193,344 | 193,344 | ||
| 2023-01-17 | Piccina Cintia Chief Commercial Officer | Grant or award · Option to purchase Ordinary Shares | +1,407,072 | 1,407,072 | ||
| 2023-01-17 | Piccina Cintia Chief Commercial Officer | Grant or award · Option to purchase Ordinary Shares | +314,256 | 314,256 | ||
| 2023-01-17 | Piccina Cintia Chief Commercial Officer | Grant or award · Option to purchase Ordinary Shares | +181,560 | 181,560 | ||
| 2023-01-17 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +4,690,224 | 4,690,224 |
Page 7 of 23 · 454 trades